TrialLeukemia2014

Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients.

G Visani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.